SCHEMBL20426196

SCHEMBL20426196

c1ccc(-n2c3ccccc3c3c4ccn(-c5cccc(-c6ccncc6)n5)c4ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MAPT P10636 4/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ROCK1 Q13464 3/20 0.34
▸ DYRK1A Q13627 1/20 0.33
▸ RXFP1 Q9HBX9 2/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20426198 0.94 L3MBTL1 (0.41) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL16357345 0.91 MAPT (0.36) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL20426240 0.88 KDM4E (0.35) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL15073668 0.87 KDM4E (0.41) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL20426299 0.87 KDM4E (0.36) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL16357485 0.85 KMT2A (0.36) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL20426285 0.82 KDM4E (0.39) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL16357585 0.82 KDM4E (0.39) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL20426239 0.82 L3MBTL1 (0.38) KDM4EATML3MBTL1MAPTKMT2A
SCHEMBL20426204 0.81 MAPT (0.41) KDM4EATML3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU KDM4E 1494/4885ATM 4017/4885L3MBTL1 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback